Neural plasticity is widely believed to support functional recovery following brain damage. Vagus nerve stimulation paired with different forelimb movements causes long-lasting map plasticity in rat primary motor cortex that is specific to the paired movement. We tested the hypothesis that repeatedly pairing vagus nerve stimulation with upper forelimb movements would improve recovery of motor function in a rat model of stroke. Rats were separated into 3 groups: vagus nerve stimulation during rehabilitation (rehab), vagus nerve stimulation after rehab, and rehab alone. Animals underwent 4 training stages: shaping (motor skill learning), prelesion training, postlesion training, and therapeutic training. Rats were given a unilateral ischemic lesion within motor cortex and implanted with a left vagus nerve cuff. Animals were allowed 1 week of recovery before postlesion baseline training. During the therapeutic training stage, rats received vagus nerve stimulation paired with each successful trial. All 17 trained rats demonstrated significant contralateral forelimb impairment when performing a bradykinesia assessment task. Forelimb function was recovered completely to prelesion levels when vagus nerve stimulation was delivered during rehab training. Alternatively, intensive rehab training alone (without stimulation) failed to restore function to prelesion levels. Delivering the same amount of stimulation after rehab training did not yield improvements compared with rehab alone. These results demonstrate that vagus nerve stimulation repeatedly paired with successful forelimb movements can improve recovery after motor cortex ischemia and may be a viable option for stroke rehabilitation.
Introduction
Stroke is the second most common cause of disability worldwide. 1 A variety of motor rehabilitation methods have been developed to improve recovery of motor function following stroke. [2] [3] [4] These methods are known to generate significant neural plasticity, yet significant deficits typically remain after motor rehabilitation. New approaches are being developed to enhance motor rehabilitation by activating brain mechanisms to direct more effective neural plasticity. [5] [6] [7] [8] Many studies have attempted to improve stroke recovery by modulating the release of neuromodulators, such as acetylcholine and norepinephrine. 9, 10 Stimulation of the left vagus nerve triggers a precisely timed burst of neuromodulators and enhances neural plasticity. 11, 12 Repeatedly pairing vagus nerve stimulation (VNS) with 2 distinct forelimb movements resulted in movement-specific map plasticity within primary motor cortex. 13 VNS is well tolerated in patients with a variety of neurological diseases 11, 14 and could be added to motor rehabilitation to improve recovery.
In this study, we evaluated whether the addition of VNS to motor rehabilitation can enhance recovery from cortical ischemia. After training on a motor task that requires rapid forelimb movement, 15 rats were injected with endothelin-1 into the rostral and caudal forelimb areas of the motor cortex. After documenting the behavioral deficit, a brief burst of VNS was delivered with each successful movement and 1006N NRXXX10.1177/1545968314521006Khodaparast et alNeurorehabilitation and Neural RepairNeurorehabilitation and Neural RepairKhodaparast et al recovery was compared with rats that received identical rehabilitation without VNS.
Methods

Subjects
Seventeen female Sprague-Dawley rats (276 ± 8 g) were used in this experiment. The rats were housed in a 12:12 hour reversed light cycle environment to increase their daytime activity levels and were food deprived to no less than 85% of their normal body weight during training as motivation for the food pellet rewards. All handling, housing, surgical procedures, and behavioral training of the rats were approved by the University of Texas Institutional Animal Care and Use Committee.
Surgical Procedures
Unilateral Ischemic Lesion. Animals were anesthetized with ketamine hydrochloride (80 mg/kg, intraperitoneal [IP]) and xylazine (10 mg/kg, IP) and given supplemental doses as needed. Sterile saline (9% NaCl solution, 10 mL total, subcutaneous [SC]) solution was given to the rats before and during the surgery to prevent dehydration throughout the surgery and recovery. Bupivicaine (1 mL, SC) was injected into the scalp and subcutaneously in the neck at the incision sites. After placing the rat in a stereotaxic frame with a digital readout (David Kopf Instruments, Tujunga, CA), an initial incision and blunt dissection of the scalp exposed the bregma and lambda landmarks on the skull. A craniotomy was performed to expose motor cortex contralateral to the trained forelimb: anteroposterior 2.75 to −0.75 mm and mediolateral 2.25 to 3.75 mm in relation to bregma. The ischemic lesion was always provided in left motor cortex since all animals trained with their right forearm. Sterile saline (9% NaCl solution) was used ad libitum to prevent cranial heat accumulation during trephination. A 26-gauge tapered Hamilton syringe was fixed to a stereotaxic guidance arm. To induce ischemia, 1.0 µL of endothelin-1 (Bachem, Torrance, CA, 1 mg/mL in saline) was injected at 8 different cortical locations within motor cortex: anteroposterior 2.5, 1.5, 0.5, and −0.5 mm and mediolateral 2.5 and 3.5 mm from bregma. The syringe needle tip was lowered to a depth of 1.8 mm from the cortical surface and endothelin-1 was administered. The fluid was injected over a 2-minute period, and the syringe remained in the brain for an additional 3 minutes to allow tissue perfusion. After the final injection, KwikCast silicone polymer (World Precision Instruments, Sarasota, FL) was placed in the craniotomy and sealed with a thin layer of acrylic.
Vagus Nerve Cuff Implantation. Following ischemic lesion, all rats received a skull-mounted 2-channel connector and a bipolar stimulating nerve cuff constructed with platinumiridium leads (5-6 kohm impedance). Four bone screws were manually drilled into the skull at points near the lambdoid suture and over the cerebellum. The 2-channel connector was attached to the cranial screws with acrylic. An incision and blunt dissection of the muscles in the neck exposed the left cervical vagus nerve. After blunt dissecting the vagus nerve from the carotid artery, the nerve was placed inside the cuff. All rats received a nerve cuff implanted around the left vagus nerve. Leads were tunneled subcutaneously and attached to the 2-channel connector atop the skull. All incisions were sutured and the exposed 2-channel connector was encapsulated in acrylic. A topical antibiotic cream was applied to both incision sites. As the animal returned to consciousness, a dose of ceftriaxone (20 mg total, SC) was administered to help prevent infection. Rats were provided with amoxicillin (5 mg) and carprofen (1 mg) in tablet form for 3 days following the surgeries and had 1 week of recovery before postlesion testing.
Behavioral Apparatus and Software
The training cage was a 20 cm × 20 cm × 20 cm wire enclosure. An automated pellet dispenser connected to a food tray on the inside of the cage. Rats reached through a 1 cm × 8 cm window slit to reach the lever outside the cage. The edge of the window was located 2 cm from the right cage wall. This arrangement restricted the rats so that they could only press the lever with their right paw. The lever was located 4.5 cm from the cage floor and at lateral distances varying from 4 cm inside to 2.5 cm outside the cage, depending on the training stage. The lever arm was affixed to a momentary switch (Med Associates, St. Albans, VT) located outside the cage. The momentary switch was connected to a digital input on the parallel port of a standard PC and trigger lines to the pellet dispenser and vagus nerve stimulator were connected to digital outputs on the same port. The state of the momentary switch was sampled every 10 ms using custom Matlab software. The software would also trigger the release of food pellet reward and trigger the VNS stimulator to deliver current to the vagus nerve cuff. Press and release times of the lever were automatically saved for offline analysis.
Bradykinesia Assessment Task
The bradykinesia assessment task allows the researcher to accurately collect hit rate performance, interpress interval, and number of presses per trial. 15 Training sessions were conducted twice daily, 5 days a week, with daily sessions separated by at least 2 hours ( Figure 1A and B ). Rats pressed the lever initially located inside the training cage to receive a sugar pellet reward (45 mg dustless precision pellet, BioServ, Frenchtown, NJ). In the first stage of training, rewards were delivered with a single press to facilitate lever-reward association. In the subsequent stages of training, a second press within a specified hit time window was required for reward delivery. A timer was initiated on the first press of the lever, and data were collected for 4 seconds. If the lever was depressed a second time within the hit time window, the trial was recorded as a success and a reward pellet was delivered ( Figure 1D and E). If the lever was not pressed again or the second press occurred after the hit time window, the trial was recorded as a failure and no reward was given. Following the 4-second data collection period, there was a 50 ms pause before rats could initiate another trial. The task was made progressively more difficult as rats met the criterion for number of successful trials within a session and progressed to the next stage. As the training stages increased, the lever was gradually retracted outside the cage and the hit time window was reduced. The values for criterion, lever location, and hit time window for the bradykinesia assessment task are detailed in Table 1 . If a rat exceeded criteria for a proceeding stage, they were automatically advanced to the stage that matched their performance. Rats were held at the prelesion stage until they The gray bars on bottom indicate miss trials were the rat failed to achieve the task requirements, no pellet or VNS delivered. (D) Sketches demonstrating the movements necessary for the bradykinesia assessment task. A rat was required to press the springloaded lever in the downward direction twice within 0.5 seconds. (E) Two examples of lever press data collected from a series of trials performed by a rat that received VNS during rehabilitation. The black dashed lines indicate the hit time window of 0.5 seconds. In the depicted hit trial, 2 presses occurred within the hit time window. Below the hit trial example, the repeated black bars demonstrate the VNS pulse train: 0.5-second 30-Hz pulse train at 0.8 mA 100-µs pulse width. The black arrowhead marks when the food pellet arrived in relation to stimulation. On the right, a miss trial occurred when a rat failed to press the lever twice within the dashed lines. No VNS or pellet was delivered. had 10 successive sessions averaging over 85% success rate. On reaching this performance level, rats were given an ischemic lesion. After 7 days of recovery, rats returned to behavioral testing with the same parameters as prelesion to allow a direct comparison of performance. To allow for accurate measurements, all rats were tested until they had 4 sessions with greater than 10 trials each at the postlesion stage. Rats then proceeded to the therapy stage where VNS was delivered on each successful trial ( Figure 1C ). The rats continued training with these parameters twice daily in 30-minute sessions for 25 days.
Application of Vagus Nerve Stimulation
Behavioral training was identical for all rats. Rats were assigned to the VNS during rehab group or the rehab group 9 days after surgery by a standardized system of alternating group assignment. The last 3 rats in the rehab group received VNS 2 hours after the second rehab session of each day. VNS was composed of approximately 7500 half-second stimulation events over 25 days. All rats had a rotating electrical tether connecting an external stimulator to the head mounted 2-channel connector. For the rehab group, the tether wires were cut to ensure no current was delivered to the vagus cuff electrode during behavioral testing.
Rats that received VNS during rehab were given a brief burst of VNS in addition to a food reward for each successful trial. VNS was delivered within 70 ms of the second lever press (ie, during the lever press). VNS was delivered as a 500-ms train of 15 pulses at 30 Hz. Each biphasic pulse was 0.8 mA in amplitude and 100 µs in phase duration. These parameters are identical to our earlier studies. 12, 13 Previous studies using the same parameters employed in this study have demonstrated changes in electroencephalographic measures and neuronal spiking synchrony during VNS, indicating that the nerve is successfully stimulated. 12, 16 Rats in the VNS after rehab group had a third session each training day during which VNS was delivered every 12 seconds for 60 minutes (300 stimulations/1-hour session) totaling 7500 stimulations over 25 days. This stimulation was given in a cage without a lever, ensuring that VNS was not delivered during lever press behavior.
Histological Processing
All rats were anesthetized with lethal dose of sodium pentobarbital (50 mg/kg, IP) and transcardially perfused with 250 mL of 0.02% heparin/0.1 M phosphate-buffered (PB) solution, followed by 450 mL of 4% paraformaldehyde/0.1 M PB solution. Brains were removed and postfixed in 4% paraformaldehyde/0.1 M PB solution, and then cryoprotected in a 30% sucrose/0.1 M PB solution. The tissue was sectioned at 40-µm intervals and stained with cresyl violet. A rat brain atlas 17 was used to help determine lesion size and location.
Statistics
All data are reported as the mean ± standard error of the mean. All comparisons were planned in the experimental design a priori, and significant differences were determined using Student t tests and/or analysis of variance. Statistical tests for each comparison are noted in the text. Histological analysis used one-way analyses of variance (ANOVAs) to compare lesion size across all groups. Behavioral data were also analyzed with ANOVA. Student t-tests were used for post-hoc analysis when appropriate for group comparisons. Significant differences are noted in the figures as *P < .05, **P < .01, and ***P < .001. Error bars indicate mean ± standard error of the mean. Trial window refers to a specified amount of time during which a second press must occur to provide an operant food pellet reward. During stage 1 of training, pellet rewards were delivered with a single press to facilitate lever-reward association. N/A denotes there was no trial window specified for the rat to press the lever. The remaining stages all required 2 presses to receive a reward. b Lever location refers to distance relative to inside cage wall. Negative values denote distance inside the cage, and positive values are outside the cage.
Results
Prelesion Performance
Prior to ET-1 ischemia, all 17 rats were able to successfully press the lever twice within 500 ms on 90.3% ± 1.0% of trials ( Figure 2 ). There was no significant difference in hit rate performance among groups, ANOVA F(2, 1) = 3.56, P = .06. The interpress interval data also showed no significance among groups, F(2, 1) = 2.61, P = .13. The rats completed the second press with an average interpress interval of 268 ± 17 ms, well within the 500-ms hit window. Rats were proficient on all measures of the task prior to lesion. Performance during earlier shaping stages have been described previously. 15 
Histology
Unilateral ET-1 injections consistently caused an ischemic lesion spanning rostral and caudal forelimb areas within motor cortex. 18 Coronal sections were collected throughout the lesion area for 13 animals. Cortical layers I to VI were destroyed by the infarct. In 10 brains, the underlying white matter (external capsule) showed no damage, the remaining 3 brains showed superficial white matter damage. Errors in histological procedures prevented analysis of the remaining 4 brains. The lesion was reconstructed using ImageJ software (National Institutes of Health, Bethesda, MD). Lesions typically ranged from anteroposterior 3.2 mm to −0.7 mm (Figure 3) . The mean ± standard deviation infarct volume across all animals was 9.38 ± 3.74 mm 3 , and one-way ANOVA showed no significant difference across all groups, F(2, 10) = 0.43, P = .66. The lesion size was consistent across groups and comparable to previous studies using similar lesion methods. 19, 20 Postlesion Performance
Unilateral ET-1 lesions worsened the hit rate performance for all 17 rats to 66.7% ± 2.8% (Figure 2 ). There was no significant difference for both hit rate performance-ANOVA F(2, 1) = 1.34, P = .49-and interpress interval-F(2, 1) = 1.34, P = .31-across groups. As expected, the lesion caused a significant decrease in hit rate of 23.6% ± 2.5% compared with prelesion performance, F(2, 1) = 56.13, P < .001. This level of impairment is consistent with other reports of rats performing a pellet grasp task with a similar ischemic lesion. 19, 20 Rats demonstrated approximately a 2-fold reduction in forearm movement speed as measured by an average interpress interval of 502 ± 33 ms (P < .001 compared with PRE; Figure 4 ). The results establish that all groups were similarly impaired in performance after ischemic lesion.
Motor Impairment Persists Even After 5 Weeks of Daily Rehabilitation
The hit rate performance of the rehab group modestly improved during the course of therapy ( Figure 2 ). Rats showed an improvement during weeks 3 to 5 compared with postlesion (P < .01 for weeks 3-5), but remained significantly impaired compared with prelesion levels throughout the entire therapy (P > .05 for all weeks). The data presented here demonstrate that motor rehabilitation only partially restores function but is insufficient to fully recover forelimb function.
Vagus Nerve Stimulation With Each Correct Movement Eliminates Motor Impairment
A repeated-measures ANOVA on hit rate performance across the postlesion interval revealed a significant effect of therapy, F(2, 84) = 18.99, P < .001, and weeks, F(5, 84) = 9.52, P < .001, without a significant interaction, F(10, 84) = 0.92, P = .52. Rats that received VNS during rehab significantly improved hit rate within the first week of therapy compared with postlesion (+12.1% ± 2.2%, P < .001; Figure 2 ). Additionally, hit rate performance Figure 2 . Lever press performance on the bradykinesia assessment task. Rats were trained to press a lever located outside the cage twice within 500 ms to receive a food reward.
Prior to the lesion (PRE), both groups were equally proficient at the task. Ischemic lesion of the motor cortex reduced performance equally in both groups (POST). During all 5 weeks of therapy, the vagus nerve stimulation (VNS) during rehab group (black) performed significantly better compared with the rehab group (gray). Data are means ± standard error of the mean. *P < .05.
improved significantly after the second week of therapy compared with the first week (+5.2% ± 2.3%, P < .05). By the third week of VNS during rehab therapy, hit rate performance was no longer significantly impaired compared with prelesion levels (VNS during rehab, PRE, 91.4% ± 1.3%; week 3, 87.1% ± 2.4%, P = .18). In contrast, rats that received rehab alone did not significantly improve after a week of therapy compared to postlesion (+4.2% ± 3.8%, P = .27) or after the second week of rehab compared with the first week (+1.1% ± 2.5%, P = .64). Performance of the rehab group was significantly reduced compared with prelesion levels at every time point. VNS delivered during motor rehabilitation induced a rapid improvement and return to prelesion performance, highlighting the beneficial effects of VNS combined with motor rehabilitation compared with rehabilitation alone.
Vagus Nerve Stimulation Did Not Improve Motor Function When Delivered After Rehabilitation
Vagus nerve stimulation delivered after rehab did not to yield improved recovery compared with rehab alone. The VNS after rehab group was significantly impaired on the task during weeks 1, 2, 4, and 5 (hit rate impairment compared with baseline at week 1, −19.4% ± 5.2%, P < .05; week 2, −14.4% ± 1.5%, P < .01; week 3, −8.9% ± 4.8%, P = .15; week 4, −12.8% ± 3.4%, P < .05; week 5, −13.9% ± 3.8%, P < .05). Because VNS after rehab offered no benefit compared to rehab only, data from rats in the VNS after rehab group were combined with data from rats receiving Interpress interval on the bradykinesia assessment task. Using the bradykinesia assessment task, forelimb movement speed is measured by the latency between the first and second lever press. Prior to lesion (PRE), both groups rapidly press the lever. After lesion (POST), the latency between lever presses is increased similarly in both groups, suggestive of a slowing of forelimb speed. During weeks 2, 3, and 5, the VNS during rehab group (black) performed significantly better compared with the rehab group (gray). Data are means ± standard error of the mean. *P < .05.
rehab only, and will be referred to as the rehab group. These results may suggest that VNS alone is not sufficient to confer therapeutic benefits.
Group Comparison Confirms the Benefit of Vagus Nerve Stimulation During Rehabilitation
Vagus nerve stimulation during rehab resulted in significantly better successful hit rate performance than the rehab group during every week of therapy (P < .05 for all weeks, Figure 2 ). On average, rats that received VNS during rehab rapidly recovered to 50% of their prelesion performance within 2.3 ± 0.4 days, while the rehab group took 10 ± 2.5 days (P < .01, Figure 5B ). Six out of 9 rats in the rehab group continued to exhibit a significant motor impairment on the last week of therapy. Only 2 of the rats in the VNS during rehab group exhibited an impairment compared with prelesion performance. All rats in the VNS during rehab group returned to 50% of their prelesion performance by week 2 (Figure 5A ). These data demonstrate that VNS during rehab provides a substantial benefit in recovery of forelimb function compared with rehab alone.
Vagus Nerve Stimulation Improves Interpress Interval
Analysis of variance on interpress interval revealed a significant effect of therapy, F(1, 4) = 14.24, P < .001, and weeks, F(1, 4) = 5.77, P < .001, without a significant interaction, F(1, 4) = 0.15, P = .96. Delivery of VNS during rehab resulted in an improvement in forelimb speed compared with the rehab group (Figure 4 ). Interpress interval returned to prelesion levels by week 3 of therapy for rats that received VNS during rehab (VNS during rehab, week 3, 288 ± 21 ms, P = .22). In contrast, rats that received rehab returned to prelesion levels by week 4 (rehab, week 4, 343 ± 36 ms, P = .17). The reduction in the time between first and second lever presses demonstrates that VNS delivered during motor rehabilitation is effective at reducing bradykinesia following ischemic lesion.
Vagus Nerve Stimulation Does Not Increase the Number of Trials
Because stimulation of the vagus nerve has a wide variety of effects, we sought to rule out several possible off-target effects. VNS during rehab did not result in a significant difference in the number of trials during the 5 weeks of therapy. Rehab rats attempted slightly more total trials compared with VNS during rehab rats (rehab, 4736 ± 237 trials; VNS during rehab, 4403 ± 388 trials), therefore increased usage of the forelimb cannot account for the improvements in performance. The body weight of each group was also not different across groups-2-way ANOVA, F(1,4) = 2.66, P = .11-suggesting that overall health was unaffected by the therapy. We never observed movement triggered by VNS. VNS also did not appear to distract rats during task performance. These observations suggest that differences in motivation or gross physiological effects are unlikely to account for the functional improvement in rats receiving VNS after each correct trial.
Discussion
This study evaluated the efficacy of pairing stimulation of the vagus nerve with forelimb movement to restore motor function after ischemic damage to motor cortex. Forelimb Figure 5 . (A) Individual rat performance on the bradykinesia assessment task. Symbols indicate when an animal regained 50% of prelesion forelimb function. X indicates that an animal that did not regain 50% of forelimb function at any point during therapy. All rats that received vagus nerve stimulation (VNS) during rehab regained 50% of forelimb function by week 2 (squares). One animal in both the rehab alone (circles) and VNS after rehab group (triangles) did not regain 50% of forelimb function. (B) Number of days for each group to regain 50% of forelimb function based on lever press success rate performance.
The VNS during rehab group demonstrated 50% recovery of prelesion performance within the first week of therapy, while rats that received rehab alone reached 50% recovery during the third week of therapy on average. Data are means ± standard error of the mean. *P < .05.
function, as measured by the bradykinesia assessment task, recovered completely when a brief burst of VNS was delivered with each successful trial. The same degree of intensive daily motor rehabilitation without VNS failed to restore normal function. These results demonstrate that VNS paired with motor training can improve recovery of forelimb function following ischemic lesion of rat motor cortex even compared to intensive daily rehabilitation. VNS thus provides a potential new method to improve stroke rehabilitation in patients. 21, 22 Neuroplasticity is thought to be the key mechanism for functional recovery after brain damage. 23 As such, many current therapies for motor rehabilitation incorporate methods to enhance plasticity with motor training. Pharmacological strategies, such as amphetamine and fluoxetine, are thought to enhance neuroplasticity by modulating neurotransmitter effects and thereby promote functional recovery. 24, 25 Stimulation of the vagus nerve causes the release of neurotransmitters that drive plasticity, including acetylcholine, norepinephrine, and serotonin. 26 Modulation of these neurotransmitters can improve functional recovery, while their ablation can occlude recovery. 9, 27, 28 Because VNS can stimulate the release of plasticity-enhancing neurotransmitters, it provides a novel means to enhance neuroplasticity.
Vagus nerve stimulation offers a much hiithgher degree of temporal precision than drugs, allowing precisely controlled release of neuromodulators and therefore more precisely targeted plasticity. Previous studies have documented the importance of precise timing of VNS in the induction of plasticity. 12, 13 VNS delivered milliseconds after forelimb movement increases the representation of the coincident movement in the motor cortex, while other movements occurring within seconds of VNS delivery did not display map plasticity. 13 VNS-directed plasticity is also spatially precise, as VNS paired with specific movements enhances only the representation of the paired movement in motor cortex. Corroborating the need for high temporal precision, VNS paired precisely with the presentation of a tone increases the representation of the paired tone in the auditory cortex and not another tone frequency that is interleaved but separated from VNS by many seconds. 12 The high temporal and spatial precision of VNS makes it possible to regulate plasticity in a moment by moment manner, such that only successful trials are paired with VNS.
The observation that our therapy improves recovery compared w a control group that received thousands of repetitions of a task that forced them to use their impaired limb (constraint-induced movement therapy) suggests that VNS can make effective rehabilitation therapies better and possibly restore normal function. It remains to be seen whether this therapy can benefit rats with more severe lesions. 29, 30 Lesions that prevent VNS from triggering release of acetylcholine or norepinephrine would be expected to block the beneficial effects of VNS, 9, 27 but this has not been shown. It is possible that careful optimization of the VNS parameters (current, pulse width, duration, etc) would be needed in such conditions. Insufficient generalization of performance gains from trained tasks to other skills often limits the impact of rehabilitation in clinical settings. 31 It would be valuable to determine whether pairing VNS with successful completion of one task could generalize to performance on another (eg, pellet retrieval). Pairing VNS with unsuccessful trials would also be important for understanding how pairing may be influencing plasticity, and whether the effects would be beneficial, detrimental, or irrelevant toward recovery.
Vagus nerve stimulation is well tolerated by patients with a wide range of neurological conditions. VNS causes no significant changes heart rate, blood oxygenation level, or resting behavior in animals, and no changes in cardiac function from basal physiological levels in patients. 11, 12, 32 More than 60 000 patients have received vagus nerve stimulation for the treatment of refractory epilepsy and depression. VNS therapy for these conditions is delivered continuously for years and only causes minor side effects. 11, 14 Pairing brief bursts of VNS with rehabilitation requires only 1% of the VNS used to treat epilepsy. 33 The minimal amount of VNS required suggests that VNS could be safely paired with rehabilitation of stroke and possibly other neurological disorders.
Conclusion/Implications
This study provides a demonstration that pairing VNS with motor rehabilitation can improve recovery following stroke. VNS delivered during motor rehabilitation restored rapid improvement and return to prelesion performance. Rehabilitation training alone was insufficient to restore normal performance. These results suggest that targeted plasticity therapy is a potentially viable new therapy for recovering motor function after stroke.
